ABCA1 and cancer: Likewise, ABCA1 downregulation caused by ABCA1 promoter hypermethylation, miR-183 degradation or loss of function mutations, led to elevated cholesterol levels in cancer cells, enhanced cell proliferation and inhibited apoptosis [305,306,307,308,309].